BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 136 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 0.65 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $1,375,000 | -43.8% | 479,902 | -25.7% | 2.71% | +57.4% |
Q2 2019 | $2,447,000 | +13.4% | 645,583 | +143.6% | 1.72% | +13.6% |
Q1 2019 | $2,157,000 | -15.9% | 265,013 | -16.6% | 1.52% | -25.0% |
Q4 2018 | $2,564,000 | +36.1% | 317,745 | -17.2% | 2.02% | +24.9% |
Q4 2017 | $1,884,000 | -0.2% | 383,768 | +6.6% | 1.62% | +8.3% |
Q3 2017 | $1,887,000 | +18.0% | 360,042 | +25.2% | 1.49% | +5.7% |
Q2 2017 | $1,599,000 | -49.3% | 287,550 | -23.4% | 1.41% | -52.5% |
Q1 2017 | $3,153,000 | +113.8% | 375,348 | +190.0% | 2.98% | -27.6% |
Q3 2015 | $1,475,000 | +66.5% | 129,415 | +31.8% | 4.11% | +145.1% |
Q1 2015 | $886,000 | – | 98,161 | – | 1.68% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DG Capital Management, LLC | 1,186,726 | $4,076,000 | 2.45% |
Sarissa Capital Management LP | 4,861,000 | $16,697,000 | 1.97% |
Ghost Tree Capital, LLC | 1,950,000 | $6,698,000 | 1.94% |
ORACLE INVESTMENT MANAGEMENT INC | 2,525,857 | $8,676,000 | 1.14% |
Eversept Partners, LP | 1,143,211 | $3,926,930 | 0.87% |
DAFNA Capital Management LLC | 749,051 | $2,573,000 | 0.84% |
KNOTT DAVID M | 397,361 | $1,365,000 | 0.80% |
Parkman Healthcare Partners LLC | 800,740 | $2,751,000 | 0.73% |
ACUTA CAPITAL PARTNERS, LLC | 660,000 | $2,267,000 | 0.62% |
Formidable Asset Management, LLC | 578,200 | $1,949,000 | 0.57% |